GRM3
Basic information
Region (hg38): 7:86643909-86864879
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 6 | 4 |
Variants in GRM3
This is a list of pathogenic ClinVar variants found in the GRM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-86765277-G-A | Benign (Dec 31, 2019) | |||
7-86765334-C-A | not specified | Uncertain significance (Aug 08, 2023) | ||
7-86765537-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
7-86786404-C-G | not specified | Uncertain significance (Nov 21, 2023) | ||
7-86786408-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
7-86786442-C-A | not specified | Uncertain significance (May 14, 2024) | ||
7-86786491-A-C | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
7-86786530-G-A | Likely benign (Feb 09, 2018) | |||
7-86786583-T-C | not specified | Uncertain significance (Dec 04, 2023) | ||
7-86786591-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
7-86786608-G-C | Likely benign (Mar 29, 2018) | |||
7-86786679-C-G | not specified | Uncertain significance (Jan 03, 2024) | ||
7-86786945-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
7-86787053-G-A | not specified | Uncertain significance (Nov 22, 2023) | ||
7-86838938-G-A | Benign (May 01, 2022) | |||
7-86838980-C-A | not specified | Uncertain significance (Aug 26, 2022) | ||
7-86838987-G-A | Likely benign (Apr 11, 2018) | |||
7-86838998-A-C | not specified | Uncertain significance (Feb 06, 2024) | ||
7-86839013-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
7-86839280-T-C | not specified | Uncertain significance (May 09, 2024) | ||
7-86839354-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
7-86839392-C-T | Likely benign (Aug 14, 2018) | |||
7-86839402-T-A | not specified | Uncertain significance (Aug 17, 2021) | ||
7-86839434-C-T | Likely benign (May 29, 2018) | |||
7-86839525-G-A | not specified | Uncertain significance (Dec 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRM3 | protein_coding | protein_coding | ENST00000361669 | 5 | 220971 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.785 | 0.215 | 125732 | 0 | 16 | 125748 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.20 | 323 | 530 | 0.609 | 0.0000323 | 5782 |
Missense in Polyphen | 109 | 244.47 | 0.44586 | 2681 | ||
Synonymous | 0.784 | 205 | 220 | 0.933 | 0.0000147 | 1738 |
Loss of Function | 4.21 | 6 | 31.5 | 0.191 | 0.00000169 | 366 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000260 | 0.000260 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000442 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000165 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity. {ECO:0000269|PubMed:8840013}.;
- Pathway
- Glutamatergic synapse - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Cocaine addiction - Homo sapiens (human);GPCRs, Class C Metabotropic glutamate, pheromone;Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Class C/3 (Metabotropic glutamate/pheromone receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;G alpha (i) signalling events;GPCR signaling-G alpha i;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.255
Intolerance Scores
- loftool
- 0.0728
- rvis_EVS
- -1.29
- rvis_percentile_EVS
- 5.08
Haploinsufficiency Scores
- pHI
- 0.494
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.603
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.674
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Grm3
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase activity;adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway;G protein-coupled glutamate receptor signaling pathway;chemical synaptic transmission;regulation of synaptic transmission, glutamatergic
- Cellular component
- plasma membrane;integral component of plasma membrane;postsynaptic density;axon;dendritic spine;glutamatergic synapse;integral component of postsynaptic membrane;integral component of presynaptic membrane
- Molecular function
- group II metabotropic glutamate receptor activity;G protein-coupled receptor activity;calcium channel regulator activity;glutamate receptor activity